Little Green Pharma Ltd Market Cap ($12.77 Million)

$12.77 Million USD  · AU$18.05 Million AUD  · Rank #26278

Market Cap & Net Worth: Little Green Pharma Ltd (LGP)

Little Green Pharma Ltd market cap. Little Green Pharma Ltd (AU:LGP) has a market capitalization of $12.77 Million (AU$18.05 Million) as of November 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #26278 globally and #1166 in its home market, demonstrating a -3.28% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Little Green Pharma Ltd's stock price AU$0.06 by its total outstanding shares 305855910 (305.86 Million). Also see LGP cash flow conversion for how efficiently the company converts equity into cash flow.

Little Green Pharma Ltd Market Cap History (2020–2026)

Little Green Pharma Ltd market cap history from 2020 to 2026. Data shows change from $122.27 Million to $12.77 Million (-23.31% CAGR). Check Little Green Pharma Ltd (LGP) share price today for real-time trading data and today's change.

Little Green Pharma Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Little Green Pharma Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore LGP net assets growth trend to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.73x

Little Green Pharma Ltd's market cap is 0.73 times its annual revenue

Industry average: 0.59x Higher than industry average

Latest Price to Earnings (P/E) Ratio

8.14x

Little Green Pharma Ltd's market cap is 8.14 times its annual earnings

Industry average: 13.94x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2020 $122.27 Million $2.20 Million -$8.28 Million 55.48x N/A
2021 $128.77 Million $7.00 Million -$4.36 Million 18.39x N/A
2022 $38.95 Million $14.04 Million -$24.07 Million 2.77x N/A
2023 $30.30 Million $19.57 Million -$9.21 Million 1.55x N/A
2024 $27.05 Million $25.63 Million -$8.15 Million 1.06x N/A
2025 $27.05 Million $36.82 Million $3.32 Million 0.73x 8.14x

Competitor Companies of LGP by Market Capitalization

Companies near Little Green Pharma Ltd in the global market cap rankings as of November 6, 2026. Also see balance sheet size of Little Green Pharma Ltd for a full breakdown of the balance sheet.

Key companies related to Little Green Pharma Ltd by market ranking:

  • Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
  • GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
  • Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
  • Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#514 Takeda Pharmaceutical Co Ltd ADR NYSE:TAK $52.60 Billion $16.65
#538 GALDERMA GROUP AG NYSE:GALDY $50.42 Billion $47.80
#588 Jiangsu Hengrui Medicine Co Ltd SHG:600276 $45.79 Billion CN¥49.05
#621 Takeda Pharmaceutical Company Limited F:TKDA $43.60 Billion €18.50

Market Capitalization of Little Green Pharma Ltd (2020–2026)

Market capitalization of Little Green Pharma Ltd from 2020 to today. Between 2020 and today, Little Green Pharma Ltd's market cap moved from $122.27 Million to $ 12.77 Million, with a yearly change of -23.31%.

Year Market Cap Change (%)
2026 AU$12.77 Million -52.80%
2025 AU$27.05 Million 0.00%
2024 AU$27.05 Million -10.71%
2023 AU$30.30 Million -22.22%
2022 AU$38.95 Million -69.75%
2021 AU$128.77 Million +5.31%
2020 AU$122.27 Million --

End of Day Market Cap According to Different Sources

On Nov 5th, 2026 the market cap of Little Green Pharma Ltd was reported to be:

Source Market Cap
Yahoo Finance $12.77 Million USD
MoneyControl $12.77 Million USD
MarketWatch $12.77 Million USD
marketcap.company $12.77 Million USD
Reuters $12.77 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Little Green Pharma Ltd

AU:LGP Australia Drug Manufacturers - Specialty & Generic
Market Cap
$12.77 Million
AU$18.05 Million AUD
Market Cap Rank
#26278 Global
#1166 in Australia
Share Price
AU$0.06
Change (1 day)
-1.67%
52-Week Range
AU$0.06 - AU$0.14
All Time High
AU$0.94
About

Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.